Hypercalcemia in Lung Cancer due to Simultaneously ElevatedPTHrP and Ectopic Calcitriol Production: First Case Report

Calcitriol-mediated hypercalcemia has been reported in malignant lymphomas and granulomatous diseases but not in lungcarcinoma. We describe a patient with squamous cell lung carcinoma with hypercalcemia and elevated calcitriol levels. A 60-year-old Caucasian male patient with stage IIIB squamous cell lung cancer developed hypercalcemia at 14.8 mg/dL two yearsafter receiving chemotherapy and radiotherapy where labs showed a serum intact PTH: 7 pg/mL, PTHrP: 30 pmol/L, 1,25-hydroxyvitamin D (calcitriol): 76 pg/mL, and 25-hydroxyvitamin D levels:<4 ng/mL. Calcitriol levels were elevated despiteundetectable 25-hydroxyvitamin D levels. There are no reported lung cancer cases with elevated calcitriol as an etiology ofhypercalcemia. We believe that the elevated calcitriol levels in this case were due to a PTHrP-independent mechanism, possiblyfrom either ectopic production of calcitriol in tumor cells or from increased activity of 1-alpha hydroxylase in the same cells. Thepatient died before the effects of prednisone therapy could be assessed. Studies are needed to investigate the cellular source ofcalcitriol and its role in hypercalcemia in patients with lung cancer.